Atopic dermatitis (eczema): open trials in Taiwan

4 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 3 · Eli Lilly and Company
National Taiwan University Hospital - Hsinchu branch, Hsinchu · Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist · Chung Shan Medical University Hospital, Taichung · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · Chang Gung Medical Foundation-Linkou Branch, Taoyuan
Registry updated 2026-10-26
NCT06947993
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Kaohsiung City · Taipei
Registry updated 2026-09-28
NCT06636240
Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis
Trial Treatment · Taipei Medical University Shuang Ho Hospital
Taipei Medical University Shuang Ho Hospital, New Taipei City
Registry updated 2025-05-25
NCT06850311
Herbal Ointment in Treating Atopic Dermatitis Topically
Trial Treatment · Phase 2/3 · En Chu Kong Hospital
En Chu Kong Hospital, New Taipei City
Registry updated 2025-02-27

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis